New drugs in ovarian cancer

Clin Adv Hematol Oncol. 2015 Apr;13(4):223-5.
No abstract available

Publication types

  • Interview

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Angiogenesis Inhibitors / therapeutic use
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Bevacizumab / pharmacology
  • Bevacizumab / therapeutic use
  • Clinical Trials as Topic
  • Drug Discovery
  • Female
  • Humans
  • Immunotherapy
  • Molecular Targeted Therapy
  • Mutation
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / mortality
  • Ovarian Neoplasms / pathology
  • Prognosis
  • Research
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Bevacizumab

Personal name as subject

  • Gini F Fleming